Introduction: There exists a knowledge gap in the quality and quantity of cancer-related research in Nigeria. This review gives a report on cancer research literature indexed in the Web of Science (WoS) in Nigeria from 1990 -2019. Materials and methods: The data used in the present study were published research papers retrieved from the Web of Science. Results: A total of 629 research articles were published within this period across 276 journals. The highest number of articles was published in 2019 (n = 62), while the least was in 1992 (n = 2). However, the last ten years witnessed explosive growth, and it accounted for 63% of the total number of articles. The most relevant authors are Olapade HI (33 articles), Huo D (28 articles), and Ogundiran TO (21 articles). The most relevant sources in the area of cancer research in Nigeria are Nigerian Journal of Clinical Practice (52 articles), East African Medical Journal (23 articles), and African Health Sciences (21 articles). The most relevant author's affiliations are University of Ibadan (n=206), University of Nigeria, Nsukka (n = 115), and Obafemi Awolowo University (n = 105). Conclusion: The results from this study show that Nigerian institutions need to collaborate extensively with foreign institutions and partner with industries in order to improve the quality of their research output.
References
1.
Garfield E. The History and Meaning of the Journal Impact Factor. JAMA. 2006;295(1):90.
2.
Adeoye RI, Okaiyeto K, Igunnu A, Oguntibeju OO. Systematic mapping of DNAzymes research from 1995 to 2019. Nucleosides, Nucleotides & Nucleic Acids. 2022;41(4):384–406.
3.
Moodley J, Singh V, Kagina BM, Abdullahi L, Hussey GD. A bibliometric analysis of cancer research in South Africa: study protocol. BMJ Open. 2015;5(2):e006913.
4.
Adeoye RI, Okaiyeto K, Oguntibeju OO. Global mapping of research outputs on nanoparticles with peroxidase mimetic activity from 2010–2019. Inorganic and Nano-Metal Chemistry. 2023;53(2):199–211.
5.
Zhang S, Zhao D, Jia W, Wang Y, Liang H, Liu L, et al. A bibliometric analysis and review of recent researches on TRPM7. Channels. 2020;14(1):203–15.
6.
Okaiyeto K, Ekundayo TC, Okoh AI. Global research trends on bioflocculant potentials in wastewater remediation from 1990 to 2019 using a bibliometric approach. Letters in Applied Microbiology. 2020;71(6):567–79.
7.
Daly B, Olopade OI. A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA: A Cancer Journal for Clinicians. 2015;65(3):221–38.
8.
Omotor DG. An Analysis of Federal Government Expenditure in the Education Sector of Nigeria: Implications for National Development. Journal of Social Sciences. 2004;9(2):105–10.
9.
Nwafor C, Nwafor N. The pattern and distribution of cancers in Akwa Ibom State, Nigeria. Nigerian Journal of Clinical Practice. 2018;21(5):603.
10.
Okobia M, Bunker C, Zmuda J, Kammerer C, Vogel V, Uche E, et al. Case-control study of risk factors for breast cancer in Nigerian women. International Journal of Cancer. 2006;119(9):2179–85.
11.
Hack TF, Crooks D, Plohman J, Kepron E. Citation analysis of Canadian psycho-oncology and supportive care researchers. Supportive Care in Cancer. 2014;22(2):315–24.
12.
Linnenluecke MK, Marrone M, Singh AK. Conducting systematic literature reviews and bibliometric analyses. Australian Journal of Management. 2020;45(2):175–94.
13.
Li T, Ho YS, Li CY. Bibliometric analysis on global Parkinson’s disease research trends during 1991–2006. Neuroscience Letters. 2008;441(3):248–52.
14.
Liu X, Zhang L, Hong S. Global biodiversity research during 1900–2009: a bibliometric analysis. Biodiversity and Conservation. 2011;20(4):807–26.
15.
Zyoud SH. Global toxocariasis research trends from 1932 to 2015: a bibliometric analysis. Health Research Policy and Systems. 2017;15(1).
16.
Sowunmi A, Alabi A, Fatiregun O, Olatunji T, Okoro U, Durosinmi Etti A. Trend of cancer incidence in an oncology center in Nigeria. West African Journal of Radiology. 2018;25(1):52.
17.
Kaufmann SH, Earnshaw WC. Induction of Apoptosis by Cancer Chemotherapy. Experimental Cell Research. 2000;256(1):42–9.
Chabner BA, Roberts TG. Chemotherapy and the war on cancer. Nature Reviews Cancer. 2005;5(1):65–72.
20.
Winawer S, Fletcher R, Miller L, Godlee F, Stolar M, Mulrow C, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology. 1997;112(2):594–642.
21.
Smith RA, Saslow D, Andrews Sawyer K, Burke W, Costanza ME, Evans WP, et al. American Cancer Society Guidelines for Breast Cancer Screening: Update 2003. CA: A Cancer Journal for Clinicians. 2003;53(3):141–69.
22.
Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, et al. The benefits and harms of breast cancer screening: an independent review. British Journal of Cancer. 2013;108(11):2205–40.
23.
Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, et al. The Global Burden of Cancer 2013. JAMA Oncology. 2015;1(4):505.
24.
Hajdu SI. A note from history: Landmarks in history of cancer, part 1. Cancer. 2011;117(5):1097–102.
25.
Sciacovelli M, Schmidt C, Maher ER, Frezza C. Metabolic Drivers in Hereditary Cancer Syndromes. Annual Review of Cancer Biology. 2020;4(1):77–97.
26.
Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA: A Cancer Journal for Clinicians. 2018;68(1):31–54.
27.
Vinceti M, Filippini T, Del Giovane C, Dennert G, Zwahlen M, Brinkman M, et al. Selenium for preventing cancer. Cochrane Database of Systematic Reviews. 2020(2).
28.
Sarwar MR, Saqib A. Cancer prevalence, incidence and mortality rates in Pakistan in 2012. Cogent Medicine. 2017;4(1):1288773.
29.
Ehrenreich B. Welcome to cancerland. Harper’s Magazine. 2001;303(1818):43–53.
30.
Chalkidou K, Marquez P, Dhillon PK, Teerawattananon Y, Anothaisintawee T, Gadelha CAG, et al. Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries. The Lancet Oncology. 2014;15(3):e119–31.
31.
Irabor D. Diet, environmental factors and increasing incidence of colorectal cancer in Nigeria. Annals of Nigerian Medicine. 2014;8(2):58.
32.
Uchendu OJ. Cancer Incidence in Nigeria: A Tertiary Hospital Experience. Asian Pacific Journal of Cancer Care. 5(1):27–32.
33.
Adetifa F, Ojikutu R. Prevalence and trends in breast cancer in Lagos state, Nigeria. African Research Review. 3(5).
34.
Watson M, Soman A, Flagg EW, Unger E, Deapen D, Chen VW, et al. Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009–2012. Preventive Medicine. 2017;103:60–5.
35.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: A Cancer Journal for Clinicians. 2015;65(1):5–29.
36.
Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. The Lancet Global Health. 2016;4(9):e609–16.
37.
Serrano B, Castellsagué X, M B. Human papillomavirus (HPV) and related cancers in the global Alliance for vaccines and immunization (GAVI. In: countries: a WHO/ICO HPV information Centre report de Sanjosé S. 2012.
38.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394–424.
39.
Busolo DS, Woodgate RL. Cancer prevention in Africa: a review of the literature. Global Health Promotion. 2015;22(2):31–9.
40.
Olaleye O, Ekrikpo U. Epidemiology of Cancers in Sub-Saharan Africa. Cancer in Sub-Saharan Africa. 2017. p. 3–19.
41.
Todua F, Gagua R, M M. Cancer incidence and mortality-Major patterns in GLOBOCAN 2012, worldwide and Georgia. Bull Georg Natl Acad Sci. 2015;9(1):168–73.
42.
Samaila M, Ayeni E, Ahmed S. Cancer pattern in a hospital-based registry. Archives of International Surgery. 2015;5(2):57.
43.
Abdulkareem F. Epidemiology and incidence of common cancers in Nigeria. In: Paper presented 2009.
44.
Lewison G, Purushotham A, Mason M, McVie G, Sullivan R. Understanding the impact of public policy on cancer research: A bibliometric approach. European Journal of Cancer. 2010;46(5):912–9.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
